×
Back to Agenda
A Hot Debate: Perspectives on Benefit and Risk From Patients Across Diseases
Session Chair(s)
Deborah Collyar
President, Patient Advocates In Research (PAIR), United States
This session provides a look at how regulators, companies, and patients can work together to discuss the benefits and risks of emerging products that can lead to better patient outcomes.
Learning Objective : Describe how regulators incorporate patient preferences into benefit/risk assessment; Identify how international efforts are building methodology for patient preferences and input into development, using case study examples.
Speaker(s)
Dinah Duarte, MSC
Signal Management Lead, European Medicines Agency, Netherlands
Rebecca Noel, DrPH, MPH
Executive Director, Benefit-Risk Assessment, Eli Lilly, United States
Have an account?